Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia

Andrew Stevenson Joel Chandranesan; Samip Master; Olivia Antosz; Breanne PeytonThomas; Nebu Koshy

doi:10.1155/2018/2849869

Case Reports in Hematology (Jan 2018)

Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia

Andrew Stevenson Joel Chandranesan,
Samip Master,
Olivia Antosz,
Breanne PeytonThomas,
Nebu Koshy

Affiliations

Andrew Stevenson Joel Chandranesan: Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA
Samip Master: Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA
Olivia Antosz: Department of Pharmacy, University Hospital, Shreveport, LA, USA
Breanne PeytonThomas: Department of Pharmacy, University Hospital, Shreveport, LA, USA
Nebu Koshy: Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA

DOI: https://doi.org/10.1155/2018/2849869
Journal volume & issue: Vol. 2018

Abstract

Read online

Rhabdomyolysis is a life-threatening syndrome due to breakdown of the skeletal muscle. It can be caused by massive trauma and crush injuries or occur as a side effect of medications. Here, we describe a case of a 33-year-old male with human immunodeficiency virus (HIV) and newly diagnosed chronic myeloid leukemia (CML) with severe life-threatening rhabdomyolysis due to a rare offending agent.

Published in Case Reports in Hematology

ISSN: 2090-6560 (Print); 2090-6579 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: https://www.hindawi.com/journals/crihem/

About the journal